Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism
Open Access
- 1 October 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (42), 32596-32605
- https://doi.org/10.1074/jbc.m110.106161
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid MalignanciesJournal of Clinical Oncology, 2009
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- Mutations in CBL occur frequently in juvenile myelomonocytic leukemiaBlood, 2009
- CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome SubtypesClinical Cancer Research, 2009
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid MalignanciesCancer Research, 2008
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeNature, 2008
- The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenesBlood, 2008
- Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemiaBlood, 2007
- Mini ReviewNegative regulation of PTK signalling by Cbl proteinsGrowth Factors, 2005
- Targeting mutated tyrosine kinases in the therapy of myeloid leukaemiasEmerging Therapeutic Targets, 2004